USE OF HEDERAGENIN 3-0 ALPHA-L-RHAMNOPYRANOSYL(1-2)-(BETA-D-GLUCOPYRANOSYL(1-4)-ALPHA-L-ARABINOPYRANOSIDE OR AN EXTRACT FROM PULSATILLAE RADIX CONTAINING THE SAME AS A THERAPEUTIC AGENT FOR SOLID TUMORS
    2.
    发明申请
    USE OF HEDERAGENIN 3-0 ALPHA-L-RHAMNOPYRANOSYL(1-2)-(BETA-D-GLUCOPYRANOSYL(1-4)-ALPHA-L-ARABINOPYRANOSIDE OR AN EXTRACT FROM PULSATILLAE RADIX CONTAINING THE SAME AS A THERAPEUTIC AGENT FOR SOLID TUMORS 有权
    HEDERAGENIN的用途3-0 ALPHA-L-RHAMNOPYRANOSYL(1-2) - (BETA-D-吡喃葡萄糖苷(1-4)-ALPHA-L-阿拉伯吡喃糖苷或从含有该固体肿瘤的治疗剂的PULSATILLAE RADIX的提取物

    公开(公告)号:US20100152124A1

    公开(公告)日:2010-06-17

    申请号:US12709907

    申请日:2010-02-22

    IPC分类号: A61K31/704 A61P35/00

    摘要: This invention relates to a use of hederagenin 3-O-α-L-rhamnopyranosyl((1→2)-[β-D-glucopyranosyl(1→4)]-α-L-arabinopyranoside or a Pulsatillae radix extract containing the same as a therapeutic agent for solid tumors. Also, this invention relates to a method of preparing a therapeutic agent for solid tumors by using hederagenin 3-O-α-L-rhamnopyranosyl(1→2)-[β-D-glucopyranosyl(1→4)]-α-L-arabinopyranoside, or a method of treating a subject suffering from solid tumors, comprising administering to the subject a therapeutically effective dose of hederagenin 3-O-α-L-rhamnopyranosyl(1→2)-[β-D-glucopyranosyl(1→4)]-α-L-arabinopyranoside.

    摘要翻译: 本发明涉及野草甘膦3-O-α-L-鼠李糖吡喃糖基((1→2) - [[b] -D-吡喃葡萄糖基(1→4)]-α-L-阿拉伯吡喃糖苷或含有 本发明涉及一种通过使用野草甘膦3-O-α-L-鼠李糖吡喃糖基(1→2) - [&bgr-D-吡喃葡萄糖基 (1→4)]-α-L-阿拉伯糖吡喃糖苷或治疗患有实体瘤的受试者的方法,包括向受试者施用治疗有效剂量的雌雄激素3-O-α-L-鼠李糖吡喃糖基(1→2) - [&bgr-D-吡喃葡萄糖基(1→4)] - α-L-阿拉伯吡喃糖苷。

    Use of hederagenin 3-O-α-L-rhamnopyranosyl(1→2)-(β-D-glucopyranosyl(1→4)-α-L-arabinopyranoside or an extract from pulsatillae radix containing the same as a therapeutic agent for solid tumors
    3.
    发明授权
    Use of hederagenin 3-O-α-L-rhamnopyranosyl(1→2)-(β-D-glucopyranosyl(1→4)-α-L-arabinopyranoside or an extract from pulsatillae radix containing the same as a therapeutic agent for solid tumors 有权
    (1→2) - (&bgr。-D-吡喃葡萄糖基(1→4)-α-L-阿拉伯吡喃糖苷或来自含有与治疗剂相同的脉冲鞭毛虫的提取物的使用 实体瘤

    公开(公告)号:US08075923B2

    公开(公告)日:2011-12-13

    申请号:US12709907

    申请日:2010-02-22

    IPC分类号: A61K36/00

    摘要: This invention relates to a use of hederagenin 3-O-α-L-rhamnopyranosyl((1→2)-[β-D-glucopyranosyl(1→4)]-α-L-arabinopyranoside or a Pulsatillae radix extract containing the same as a therapeutic agent for solid tumors. Also, this invention relates to a method of preparing a therapeutic agent for solid tumors by using hederagenin 3-0-α-L-rhamnopyranosyl(1→2)-[β-D-glucopyranosyl(1→4)]-α-L-arabinopyranoside, or a method of treating a subject suffering from solid tumors, comprising administering to the subject a therapeutically effective dose of hederagenin 3-0-α-L-rhamnopyranosyl(1→2)-[β-D-glucopyranosyl(1→4)]-α-L-arabinopyranoside.

    摘要翻译: 本发明涉及野草甘膦3-O-α-L-鼠李糖吡喃糖基((1→2) - [[b] -D-吡喃葡萄糖基(1→4)]-α-L-阿拉伯吡喃糖苷或含有 本发明还涉及通过使用雄激素3-0-α-L-鼠李糖吡喃糖基(1→2) - [&bgr-D-吡喃葡萄糖基 (1→4)]-α-L-阿拉伯吡喃糖苷或治疗患有实体瘤的受试者的方法,包括向受试者施用治疗有效剂量的雌雄激素3-0-α-L-鼠李糖吡喃糖基(1→2) - [&bgr-D-吡喃葡萄糖基(1→4)] - α-L-阿拉伯吡喃糖苷。

    Use of hederagenin 3-O-α-L-rhamnopyranosyl(1-2)-[β-D-glucopyranosyl(1-4)]-α-L-arabinopyranoside or an extract from pulsatillae radix containing the same as a therapeutic agent for solid tumors
    4.
    发明授权
    Use of hederagenin 3-O-α-L-rhamnopyranosyl(1-2)-[β-D-glucopyranosyl(1-4)]-α-L-arabinopyranoside or an extract from pulsatillae radix containing the same as a therapeutic agent for solid tumors 有权
    (1-2) - [&bgr-D-吡喃葡萄糖基(1-4)]-α-L-阿拉伯吡喃糖苷或来自含有与治疗剂相同的脉孢菌的提取物的使用 用于实体瘤

    公开(公告)号:US07682638B2

    公开(公告)日:2010-03-23

    申请号:US11107665

    申请日:2005-04-15

    IPC分类号: A61K36/00 A01N43/04

    摘要: This invention relates to a use of hederagenin 3-O-α-L-rhamnopyranosyl((1→2)-[β-D-glucopyranosyl(1→4)]-α-L-arabinopyranoside or a Pulsatillae radix extract containing the same as a therapeutic agent for solid tumors. Also, this invention relates to a method of preparing a therapeutic agent for solid tumors by using hederagenin 3-0-α-L-rhamnopyranosyl(1→2)-[β-D-glucopyranosyl(1→4)]-α-L-arabinopyranoside, or a method of treating a subject suffering from solid tumors, comprising administering to the subject a therapeutically effective dose of hederagenin 3-0-α-L-rhamnopyranosyl(1→2)-[β-D-glucopyranosyl(1→4)]-α-L-arabinopyranoside.

    摘要翻译: 本发明涉及野草甘膦3-O-α-L-鼠李糖吡喃糖基((1→2) - [[b] -D-吡喃葡萄糖基(1→4)]-α-L-阿拉伯吡喃糖苷或含有 本发明还涉及通过使用雄激素3-0-α-L-鼠李糖吡喃糖基(1→2) - [&bgr-D-吡喃葡萄糖基 (1→4)]-α-L-阿拉伯吡喃糖苷或治疗患有实体瘤的受试者的方法,包括向受试者施用治疗有效剂量的雌雄激素3-0-α-L-鼠李糖吡喃糖基(1→2) - [&bgr-D-吡喃葡萄糖基(1→4)] - α-L-阿拉伯吡喃糖苷。